MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2018 International Congress

    Using Vision to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, S. Hewitt, M. Durteste, F. Bremner, M. Lai, L. Miller, A. Saygin, C. Song, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

    Objective: To identify visual measures that relate to higher risk of dementia in Parkinson’s Disease (PD). Background: Dementia affects 50% of people with PD within…
  • 2018 International Congress

    Biomarkers of rapid progression of cognitive decline in Parkinson’s disease

    S. Martinez-Horta, F. Sampedro, J. Pagonabarraga, J. Marin-Lahoz, A. Horta-Barba, H. Bejr-Kasem, I. Aracil, J. Perez-Perez, MA. Boti, J. Kulisevsky. (Barcelona, Spain)

    Objective: We aimed to explore cross-sectional grey-matter volume (GMV) and CSF biomarkers differences in PD patients exhibiting a rapid progression of cognitive decline compared to…
  • 2018 International Congress

    The Parkinson’s Families Project: A family-based study of early onset and familial Parkinson’s disease

    M. Tan, A. Costantini, S. Lubbe, E. Brown, J. Bras, N. Wood, A. Schapira, J. Hardy, H. Morris (London, United Kingdom)

    Objective: The aim of this study is to identify new genetic variants that cause or predispose to Parkinson’s disease (PD). Our secondary aim is to…
  • 2018 International Congress

    The Clinical Research of Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder

    Y. Wang, Z. Liang (Dalian, China)

    Objective: To compare the differences of clinical characteristics between PD patients with rapid eye movement sleep behavior disorder (RBD) (RBD+ group) and those without RBD…
  • 2018 International Congress

    Lewy body disease with visual hallucination: Optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

    M. Miyata, S. Kakeda, T. Yoneda, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We assessed structural abnormalities of optic radiation (OR) in healthy subjects (HS) and dementia with lewy body (DLB) patients (with visual hallucination) (VH) on…
  • 2018 International Congress

    Identification of Comprehensive PD Subtypes Using PPMI Study Data with Recurrent Neural Networks

    X. Zhang, Y. Zhao, H. Sarva, C. Henchcliffe, F. Wang (New York, NY, USA)

    Objective: To identify Parkinson’s disease (PD) subtypes that demonstrate a specific progression pattern, using study data from the Parkinson’s Progression Markers Initiative (PPMI) cohort. Background:…
  • 2018 International Congress

    Sex Differences in Cognitive Performance in De-Novo Parkinson’s Disease

    S. Banks, E. Bayram, J. Kaylegian, B. Bluett (Las Vegas, NV, USA)

    Objective: To investigate whether sex affects cognition in patients with de-novo Parkinson’s disease (PD). Background: Sex differences in PD are common and may be due…
  • 2018 International Congress

    Characteristics in relation to demographic, disease related and clinical variables of a cohort of Parkinson’s disease patients from Northern Sri Lanka

    A. Keshavaraj, S. Kunathilagam (Jaffna, Sri Lanka)

    Objective: To evaluate motor and non-motor domains, as well as for demographic and disease related characteristics of patients with Parkinson’s disease and the relations with…
  • 2018 International Congress

    Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson’s disease

    T. Stojkovic, E. Stefanova, I. Soldatovic, V. Markovic, I. Stankovic, F. Agosta, I. Petrovic, S. Galantucci, M. Filippi, V. Kostic (Belgrade, Serbia)

    Objective: To determine frequency and type of cognitive disorders in cross-sectional analysis of a Parkinson’s disease (PD) cohort, and explore its relations to motor symptoms,…
  • 2018 International Congress

    A pilot study of plasma ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) as a potential blood-based biomarker in Parkinson’s disease

    A. Ng, YJ. Tan, ZH. Lu, S. Ng, E. Ng, F. Setiawan, N. Keong, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: To determine plasma levels of UCH-L1 in patients with PD, and to investigate the association with both genetic (leucine-rich repeat kinase 2, LRRK2 and…
  • « Previous Page
  • 1
  • …
  • 74
  • 75
  • 76
  • 77
  • 78
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley